Here are relevant reports on : oral-contraceptive-market
-
Virology Specimen Collection Market by Product (Viral Transport Media, Swabs, Blood Collection Kits, Specimen Collection Tubes), Sample Type (Blood, Cervical, Nasal, Nasopharyngeal, Throat, Oral), Region - Global Forecast to 2026
The global Virology Specimen Collection Market boasts a total value of $5.6 billion in 2021 and is projected to register a growth rate of -0.6% to reach a value of $5.4 billion by 2026. The major players operating in this market are Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific, Inc. (US), Trinity Biotech (Ireland), Titan Biotech, Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.p.A. (Italy), Puritan Medical Products, Co. (Guilford, ME) and Hardy Diagnostics (US).
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1, GPE, CGRP), Therapeutic Area (Nephrology, Gastroenterology, Genetic, CNS, Obesity, Diabetes), Formulation (Tablet, Capsule) - Global Forecast to 2030
The global oral proteins and peptides market, valued at US$8.07 billion in 2024, stood at US$9.31 billion in 2025 and is projected to advance at a resilient CAGR of 16.4% from 2025 to 2030, culminating in a forecasted valuation of US$19.93 billion by the end of the period. This growth is driven by several factors, including the rising prevalence of chronic diseases such as diabetes, gastrointestinal disorders, and kidney diseases.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery (Oral, Injectables, Topical), Packaging Type, Raw Material, And Country - Forecast to 2030
The Asia Pacific pharmaceutical packaging market is projected to grow from USD 52.15 billion in 2025 to USD 119.48 billion by 2030, at a CAGR of 18% during the forecast period. The key players in the Asia Pacific pharmaceutical packaging market include Amcor plc (Switzerland), Gerresheimer AG (Germany), SCHOTT AG (Germany), Becton Dickinson & Co (US), WestRock Company (Ireland), AptarGroup, Inc (US), West Pharmaceutical Services, Inc (US), Parekhplast India Ltd. (India), Nipro Corporation (Japan), and SGD Pharma (France).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Latin America Pharmaceutical Drug Delivery Market by Route of Administration [Injectable (Prefilled Syringe, Self Injection Devices), Oral (Tablet, Capsule, Liquid), Topical, Buccal, Nasal, Rectal], Application (Cancer, Diabetes, CVD) - Forecast to 2031
The latin america pharmaceutical drug delivery market, valued at USD 72.7BN in 2025, stood at USD 75.3BN in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 102.1BN by the end of the period. Some of the prominent players in the Latin America pharmaceutical drug delivery market include Pfizer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Sanofi (France), AstraZeneca (UK), GSK Plc (UK), Eurofarma (Brazil), Bayer AG (Germany), EMS (Brazil), BD (US), Teva Pharmaceutical Industries Ltd. (Israel), and Hypera Pharma (Brazil).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033
The global GLP-1 analogues market, valued at US$53.74 billion in 2024, stood at US$64.42 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2033, culminating in a forecasted valuation of US$170.75 billion by the end of the period. The market for GLP-1 agonists is highly consolidated, with key players strategizing to capture the market. Prominent players in the GLP-1 agonists market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), among other players.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
CBCT/Cone Beam Imaging Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontics, Endodontics), Patient Position (Standing/Sitting, Seated, Supine), End User (Hospital, Private Practice) - Global Forecast to 2021
The global CBCT/Cone beam imaging market is expected to reach USD 801.2 Million by 2021 from USD 494.4 Million in 2016, at a CAGR of 10.1% during the forecast period (2016-2021). Factors such as increasing prevalence of dental disorders, growth in geriatric population, growing demand for cosmetic dentistry, and expanding applications of CBCT systems are expected to fuel growth in the CBCT systems market in the coming few years.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast to 2021
The global sugar excipients market is projected to reach USD 1,060.6 Million by 2021 from USD 860.6 Billion in 2016, at a CAGR of 4.3% from 2016 to 2021. The sugar excipients market is expected to witness significant growth in the coming years due to the increasing use of co-processed excipients, rapid growth in the generics market due to the patent expiration of many blockbuster drugs, and increasing development of orally disintegrating tablets (ODTs).
- Published: December 2016
- Price: $ 4950
- TOC Available:
-
Companion Animal Pharmaceuticals Market by Animal Type (Dogs, Cats, Horses), Route of Administration (Oral, Injectable, Topical), Indication (Antibiotics, Parasiticides), Distribution Channel (Veterinary Hospitals & Clinics) & Region - Global Forecasts to 2027
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Cosmetic Products Market by Type (Skin, Hair, Sun, Oral, Fragrance, Color, Soap, Bath, Shower, Personal Hygiene), Distribution Channel (Supermarket, Pharmacy, Departmental, Specialty, Direct, Internet, Salon) & Geography - Global Trends & Forecasts to 2019
Cosmetic products are manufactured by using chemicals, minerals, and some natural ingredients. Technological advancement in the manufacturing of cosmetic products is one of the driving factors for the cosmetic products market. The economic development in the emerging countries has further increased the utilization of cosmetic products as consumers have more disposable income.
- Published: April 2014
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
